HDFC Mutual Fund (scheme HDFCRETHDP)
Alembic Pharmaceuticals Limited · NSE
5,000 sh · ₹39.85 L
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
2.4% of their portfolio
₹165.58 Cr
20,77,449 sh
ICICI Prudential Smallcap Fund
0.4% of their portfolio
₹41.05 Cr
5,15,066 sh
ICICI Prudential Manufacturing Fund
0.5% of their portfolio
₹34.50 Cr
4,32,878 sh
Aditya Birla Sun Life Pharma & Healthcare Fund
1.3% of their portfolio
₹12.16 Cr
1,61,057 sh
HDFC Retirement Savings Fund - Hybrid-Equity Plan
61.0% of their portfolio
₹9.96 Cr
1,25,000 sh
ICICI Prudential Children’s Fund
0.7% of their portfolio
₹9.87 Cr
1,20,000 sh
ICICI Prudential Children Fund
0.7% of their portfolio
₹9.56 Cr
1,20,000 sh
Chirayu Ramanbhai Amin HUF
Investor
₹1.39 Cr
98,268 sh
HDFC Mutual Fund (scheme HDFCRETHDP)
27.0% of their portfolio
₹39.85 L
5,000 sh
Groww Mutual Fund (scheme VD)
0.5% of their portfolio
₹36.46 L
4,953 sh
Nirayu Private Limited
Investor
₹24.37 L
2,76,110 sh
Groww Mutual Fund (scheme IB18)
0.0% of their portfolio
₹8.10 L
985 sh
FII holding ~flat QoQ
Jun 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
HDFC Mutual Fund (scheme HDFCRETHDP)
Alembic Pharmaceuticals Limited · NSE
5,000 sh · ₹39.85 L
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Alembic Pharmaceuticals Limited · NSE
20,77,449 sh · ₹165.58 Cr
HDFC Retirement Savings Fund - Hybrid-Equity Plan
Alembic Pharmaceuticals Limited · NSE
1,25,000 sh · ₹9.96 Cr
ICICI Prudential Manufacturing Fund
Alembic Pharmaceuticals Limited · NSE
4,32,878 sh · ₹34.50 Cr
Groww Mutual Fund (scheme NI)
Alembic Pharmaceuticals Limited · NSE
986 sh · ₹7.86 L
ICICI Prudential Smallcap Fund
Alembic Pharmaceuticals Limited · NSE
5,15,066 sh · ₹41.05 Cr
ICICI Prudential Children Fund
Alembic Pharmaceuticals Limited · NSE
1,20,000 sh · ₹9.56 Cr
ICICI Prudential Children’s Fund
Alembic Pharmaceuticals Limited · NSE
1,20,000 sh · ₹9.87 Cr
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
31 announcements on record for this company.
Promoter holding by quarter: Jun 2025 69.7%, Sep 2025 69.7%, Dec 2025 69.7%, Mar 2026 69.7%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— 0.0pp
FII holding by quarter: Jun 2025 4.0%, Sep 2025 4.0%, Dec 2025 4.2%, Mar 2026 4.3%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— 0.0pp
DII holding by quarter: Jun 2025 16.5%, Sep 2025 16.3%, Dec 2025 16.2%, Mar 2026 16.2%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— 0.0pp
MF holding by quarter: Jun 2025 9.1%, Sep 2025 8.6%, Dec 2025 8.2%, Mar 2026 8.2%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
HDFC Retirement Savings Fund - Hybrid-Equity Plan
Alembic Pharmaceuticals Limited · NSE
1,25,000 sh · ₹10.28 Cr
HDFC Mutual Fund (scheme HDFCRETHDP)
Alembic Pharmaceuticals Limited · NSE
5,000 sh · ₹41.14 L
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Jun 2025 69.7%, Sep 2025 69.7%, Dec 2025 69.7%, Mar 2026 69.7%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— 0.0pp
FII holding by quarter: Jun 2025 4.0%, Sep 2025 4.0%, Dec 2025 4.2%, Mar 2026 4.3%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— 0.0pp
DII holding by quarter: Jun 2025 16.5%, Sep 2025 16.3%, Dec 2025 16.2%, Mar 2026 16.2%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— 0.0pp
MF holding by quarter: Jun 2025 9.1%, Sep 2025 8.6%, Dec 2025 8.2%, Mar 2026 8.2%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
31 announcements on record for this company.